Page last updated: 2024-08-26

prolinedithiocarbamate and Bowel Diseases, Inflammatory

prolinedithiocarbamate has been researched along with Bowel Diseases, Inflammatory in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andoh, A; Araki, Y; Bamba, S; Bamba, T; Fujino, S; Fujiyama, Y; Hata, K; Okuno, T; Shimada, M1

Other Studies

1 other study(ies) available for prolinedithiocarbamate and Bowel Diseases, Inflammatory

ArticleYear
IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts.
    American journal of physiology. Gastrointestinal and liver physiology, 2002, Volume: 282, Issue:6

    Topics: Antineoplastic Agents; Cells, Cultured; Chemokine CCL2; Colon; Enzyme Inhibitors; Fibroblasts; Gene Expression; Humans; Inflammatory Bowel Diseases; Interleukin-1; Interleukin-17; Interleukin-6; Interleukin-8; Mitogen-Activated Protein Kinases; NF-kappa B; Proline; Protein Synthesis Inhibitors; RNA, Messenger; Thiocarbamates; Tosylphenylalanyl Chloromethyl Ketone; Tumor Necrosis Factor-alpha

2002